OPKO Health, Inc. (OPK) Revenue by Segment & Business Profile
Pharmaceutical was 54.4% of OPKO Health, Inc.'s revenue across the 2 lines it reports, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OPKOPKO Health, Inc.Follow OPK — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
What the company does
OPKO Health, Inc. is a diagnostics & research company in the healthcare sector. In its SEC filings it reports 2 business lines: Pharmaceutical (54%), Diagnostics (46%). Trailing twelve-month revenue: $587.9 million as of 2026-06-30.
Roles we read
from the filings, not the sector label- Clinical diagnostics
- Drug discovery / CRO
Revenue by geography
latest quarter · company segment note| Region | Revenue | Share | y/y |
|---|---|---|---|
| United States | 89M | 54.3% | -22.7% |
| Ireland | 42M | 25.5% | +254.8% |
| CL | 16M | 10.0% | +2.7% |
| ES | 8M | 5.2% | +25.7% |
| Mexico | 7M | 4.3% | +11.8% |
| Other Countries | 1M | 0.7% | +16.5% |
OPKO Health, Inc. — questions
- What does OPKO Health, Inc. do?
- OPKO Health, Inc. is a diagnostics & research company in the healthcare sector. In its SEC filings it reports 2 business lines: Pharmaceutical (54%), Diagnostics (46%). Trailing twelve-month revenue: $587.9 million as of 2026-06-30.
- How does OPKO Health, Inc. make money?
- By the lines it reports in its SEC filings: Pharmaceutical 54.4%, Diagnostics 45.6% of revenue.
Every figure on this page comes from OPKO Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.